Increased risk of respiratory diseases in adults with Type 1 and Type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 142, Issue , 2018, Pages 46-55

  George, Chelsey ^a   Ducatman, Alan M ^a   Conway, Baqiyyah N ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PERFLUOROOCTANOIC ACID;

ADULT; AGE; ARTICLE; ASTHMA; BODY MASS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EMPHYSEMA; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICIPATORY RESEARCH; PHENOTYPIC VARIATION; RESPIRATORY TRACT DISEASE; RISK FACTOR; SELF REPORT; SMOKING HABIT; COMPLICATION; LUNG; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; ASTHMA; BRONCHITIS, CHRONIC; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 85047838225     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2018.05.029     Document Type: Article

References (49)

1. Conway, B.N., May, M.E., Signorello, L.B., Blot, W.J., Mortality experience of a low-income population with young-onset diabetes. Diabetes Care 35:3 (2012), 542–548.
2. Conway, B.N., May, M.E., Fischl, A., Frisbee, J., Han, X., Blot, W.J., Cause-specific mortality by race in low-income Black and White people with Type 2 diabetes. Diabetic Med: J Br Diabetic Assoc 32:1 (2015), 33–41.
3. Schuyler, M.R., Niewoehner, D.E., Inkley, S.R., Kohn, R., Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 113:1 (1976), 37–41.
4. Sandler, M., Bunn, A.E., Stewart, R.I., Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 135:1 (1987), 223–229.
5. Goldman, M.D., Lung dysfunction in diabetes. Diabetes Care 26:6 (2003), 1915–1918.
6. Yeh, H.C., Punjabi, N.M., Wang, N.Y., Pankow, J.S., Duncan, B.B., Cox, C.E., et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 31:4 (2008), 741–746.
7. Fogarty, A.W., Jones, S., Britton, J.R., Lewis, S.A., McKeever, T.M., Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 62:6 (2007), 515–520.
8. Davis, W.A., Knuiman, M., Kendall, P., Grange, V., Davis, T.M., Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 27:3 (2004), 752–757.
9. Yonchuk, J.G., Silverman, E.K., Bowler, R.P., Agusti, A., Lomas, D.A., Miller, B.E., et al. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung. Am J Respir Crit Care Med 192:7 (2015), 785–792.
10. Smit, P.J., Guo, W.A., Davidson, B.A., Mullan, B.A., Helinski, J.D., Knight, P.R. 3rd., Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury. J Surg Res 191:1 (2014), 214–223.
11. Downs, C.A., Kreiner, L.H., Johnson, N.M., Brown, L.A., Helms, M.N., Receptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels. Am J Respir Cell Mol Biol 52:1 (2015), 75–87.
12. Walter, R.E., Beiser, A., Givelber, R.J., O'Connor, G.T., Gottlieb, D.J., Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 167:6 (2003), 911–916.
13. Chance, W.W., Rhee, C., Yilmaz, C., Dane, D.M., Pruneda, M.L., Raskin, P., et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 31:8 (2008), 1596–1601.
14. Williams, J.G., Morris, A.I., Hayter, R.C., Ogilvie, C.M., Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise. Thorax 39:7 (1984), 529–534.
15. Jermendy, G., Toth, L., Voros, P., Kiraly, M., Perenyi, J., Kammerer, L., et al. Impairment of cardiorespiratory reflexes and its association with distal somatic neuropathy in diabetic patients free from clinical symptoms of autonomic neuropathy. Exp Clin Endocrinology 96:2 (1990), 199–206.
16. Frisbee, S.J., Brooks, A.P. Jr., Maher, A., Flensborg, P., Arnold, S., Fletcher, T., et al. The C8 health project: design, methods, and participants. Environ Health Perspect 117:12 (2009), 1873–1882.
17. MacNeil, J., Steenland, N.K., Shankar, A., Ducatman, A., A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 109:8 (2009), 997–1003.
18. Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.F. 3rd, Feldman, H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:9 (2009), 604–612.
19. Gerstman, B.B., Epidemiology Kept Simple. 2013, Wiley-Blackwell, West Sussex, UK.
20. Lange, P., Parner, J., Schnohr, P., Jensen, G., Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 20:6 (2002), 1406–1412.
21. Mannino, D.M., Thorn, D., Swensen, A., Holguin, F., Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32:4 (2008), 962–969.
22. Glaser, S., Kruger, S., Merkel, M., Bramlage, P., Herth, F.J., Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature. Respir; Int Rev Thoracic Dis 89:3 (2015), 253–264.
23. Rana, J.S., Mittleman, M.A., Sheikh, J., Hu, F.B., Manson, J.E., Colditz, G.A., et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 27:10 (2004), 2478–2484.
24. Ehrlich, S.F., Quesenberry, C.P. Jr., Van Den Eeden, S.K., Shan, J., Ferrara, A., Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 33:1 (2010), 55–60.
25. Strojek, K., Ziora, D., Sroczynski, J.W., Oklek, K., Pulmonary complications of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:12 (1992), 1173–1176.
26. Fuso, L., Cotroneo, P., Basso, S., De Rosa, M., Manto, A., Ghirlanda, G., et al. Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 110:4 (1996), 1009–1013.
27. Mancini, M., Filippelli, M., Seghieri, G., Iandelli, I., Innocenti, F., Duranti, R., et al. Respiratory muscle function and hypoxic ventilatory control in patients with type I diabetes. Chest 115:6 (1999), 1553–1562.
28. Ofulue, A.F., Thurlbeck, W.M., Experimental diabetes and the lung. II. In vivo connective tissue metabolism. Am Rev Respir Dis 138:2 (1988), 284–289.
29. Sugahara, K., Ushijima, K., Morioka, T., Usuku, G., Studies of the lung in diabetes mellitus. I. Ultrastructural studies of the lungs in alloxan-induced diabetic rats. Virchows Archiv A, Pathological Anatomy Histology 390:3 (1981), 313–324.
30. Weynand, B., Jonckheere, A., Frans, A., Rahier, J., Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration; Int Rev Thoracic Dis 66:1 (1999), 14–19.
31. Hancox, R.J., Poulton, R., Greene, J.M., Filsell, S., McLachlan, C.R., Rasmussen, F., et al. Systemic inflammation and lung function in young adults. Thorax 62:12 (2007), 1064–1068.
32. Thyagarajan, B., Jacobs, D.R., Apostol, G.G., Smith, L.J., Lewis, C.E., Williams, O.D., Plasma fibrinogen and lung function: the CARDIA Study. Int J Epidemiol 35:4 (2006), 1001–1008.
33. Pitocco, D., Fuso, L., Conte, E.G., Zaccardi, F., Condoluci, C., Scavone, G., et al. The diabetic lung–a new target organ?. Rev Diabetic Studies: RDS 9:1 (2012), 23–35.
34. Dong, G.H., Tung, K.Y., Tsai, C.H., Liu, M.M., Wang, D., Liu, W., et al. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ Health Perspect 121:4 (2013), 507–513.
35. Humblet, O., Diaz-Ramirez, L.G., Balmes, J.R., Pinney, S.M., Hiatt, R.A., Perfluoroalkyl chemicals and asthma among children 12–19 years of age: NHANES (1999–2008). Environ Health Perspect 122:10 (2014), 1129–1133.
36. Steenland, K., Zhao, L., Winquist, A., A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). Occupational Environ Med 72:5 (2015), 373–380.
37. Okura, Y., Urban, L.H., Mahoney, D.W., Jacobsen, S.J., Rodeheffer, R.J., Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57:10 (2004), 1096–1103.
38. Manson, J.E., Colditz, G.A., Stampfer, M.J., Willett, W.C., Krolewski, A.S., Rosner, B., et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151:6 (1991), 1141–1147.
39. Molenaar, E.A., Van Ameijden, E.J.C., Grobbee, D.E., Numans, M.E., Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. Eur J Public Health 17:2 (2007), 199–205.
40. Dey, A.K., Alyass, A., Muir, R.T., Black, S.E., Swartz, R.H., Murray, B.J., et al. Validity of Self-Report of Cardiovascular Risk Factors in a Population at High Risk for Stroke. J Stroke Cerebrovasc Dis 24:12 (2015), 2860–2865.
41. Huerta, J.M., Tormo, M.J., Egea-Caparros, J.M., Ortola-Devesa, J.B., Navarro, C., Accuracy of self-reported diabetes, hypertension and hyperlipidemia in the adult Spanish population. DINO Study Finds Rev Esp Cardiol 62:2 (2009), 143–152.
42. Schneider, A.L., Pankow, J.S., Heiss, G., Selvin, E., Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study. Am J Epidemiology 176:8 (2012), 738–743.
43. Hawa, M.I., Kolb, H., Schloot, N., Beyan, H., Paschou, S.A., Buzzetti, R., et al. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 36:4 (2013), 908–913.
44. Mueller, N.T., Koh, W.P., Odegaard, A.O., Gross, M.D., Yuan, J.M., Pereira, M.A., Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study. Diabetes Res Clin Pract 99:2 (2013), 192–199.
45. Klein, O.L., Krishnan, J.A., Glick, S., Smith, L.J., Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabetic Med: J Br Diabetic Assoc 27:9 (2010), 977–987.
46. Lange, P., Groth, S., Mortensen, J., Appleyard, M., Nyboe, J., Schnohr, P., et al. Diabetes mellitus and ventilatory capacity: a five year follow-up study. Eur Respir J 3:3 (1990), 288–292.
47. Antonelli Incalzi, R., Fuso, L., Pitocco, D., Basso, S., Trove, A., Longobardi, A., et al. Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study. Diabetes/Metab Res Rev 23:4 (2007), 311–316.
48. Weiss, S.R., Cheng, S.L., Kourides, I.A., Gelfand, R.A., Landschulz, W.H., Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial. Archives Intern Med 163:19 (2003), 2277–2282.
49. Skyler, J.S., Weinstock, R.S., Raskin, P., Yale, J.F., Barrett, E., Gerich, J.E., et al. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. Diabetes Care 28:7 (2005), 1630–1635.